-
Impact of Polatuzumab Vedotin as First-Line Therapy for DLBCL on Subsequent Treatments: Brazilian Model
Mar 10, 2025, 14:00 PM -
Predictive Models and Risk Scoring System Development for Assessing Survival in Uterine Cancer Patients With Type 2 Diabetes Mellitus: A Territory-Wide Cohort Study
Mar 10, 2025, 14:00 PM -
A Cost-Effectiveness Analysis of Diagnostic Testing in Alzheimer's Disease
Mar 10, 2025, 14:00 PM -
Assessing the Impact of PD-L1 and BRAF Biomarkers on Long-Term Survivorship (LTS) Rates Among Treatment-Naive Advanced Melanoma Patients Receiving Immune Checkpoint Inhibitors (ICIs)
Mar 10, 2025, 14:00 PM -
The Role of Absolute Summaries in Detecting Intransitivity and Model Mis-Specification in Indirect Treatment Comparisons
Mar 10, 2025, 14:00 PM -
A Framework for Evaluating the Economic and Operational Impact of Adopting the Sentimag®platform for Lesion Localization and Sentinel Lymph Node Biopsy in Women with Breast Cancer
Mar 10, 2025, 14:00 PM -
Exploring the Link Between Self-Efficacy and Medication Adherence: Psychometric Evaluation of the Traditional Chinese Beliefs About Medicines Questionnaire-Specific in Adults With Type 2 Diabetes
Mar 10, 2025, 14:00 PM -
Dual Inhibitor Identification for Mutated IDH1/2 To Reduce D-2-Hydroxyglutarate in Glioblastoma
Mar 10, 2025, 14:00 PM -
Impact of Route of Administration and HCP- or Self-Administration on Pricing of Non-Oncology Orphan Products, 2015-2024
Mar 10, 2025, 14:00 PM -
Costs and Resource Optimization in the Rheumatoid Arthritis Care Pathway: A TDABC-Based Analysis in a Clinic in São Paulo
Mar 10, 2025, 14:00 PM -
HTA Assessments for Multipurpose Contrast Agents: Insights and Solutions to Formal HTA Challenges
Mar 10, 2025, 14:00 PM -
Analysis of Antibody-Drug Conjugate Usage in Patients Undergoing Circulating Tumor DNA Testing
Mar 10, 2025, 14:00 PM -
Redesigning the Care Process to Improve the Experience of Patients with Multiple Sclerosis Throughout the Patient Journey. EMpodera
Mar 10, 2025, 14:00 PM -
Development and Validation of the Symptom Assessment for Bronchiectasis (SABRE) for the FDA Qualification Program: A Novel Patient-Reported Outcome Instrument to Measure Symptoms of Non-Cystic Fibrosis Bronchiectasis
Mar 10, 2025, 14:00 PM -
Assessing Antipsychotic Adherence in People With Cognitive Impairment Associated With Schizophrenia: A US Non-Interventional Cohort Study of Real-World Data
Mar 10, 2025, 14:00 PM -
Cost and Clinical Characteristics of Acute Pancreatitis Hospitalizations Related and Unrelated to Hypertriglyceridemia
Mar 10, 2025, 14:00 PM -
Modeling the Potential Public Health Impact and Cost-Effectiveness of BNT162b2 COVID-19 Adapted Booster Vaccination in Guatemala
Mar 10, 2025, 14:00 PM -
Clinical and Economic Analysis in Rheumatoid Arthritis Treatment: A Managed Care Experience
Mar 10, 2025, 14:00 PM -
Cost-Effectiveness Analysis of Rosuvastatin and Ezetimibe Single Pill Combination (SPC) Versus Free Combination Treatment (FCT) in Chinese Hypercholesterolemia Adult Patients
Mar 10, 2025, 14:00 PM -
Impact of Automated Insulin Delivery System (AID) Adoption on Concomitant Non-Insulin Diabetes Medications in Patients With Type 2 Diabetes for a U.S. Payer
Mar 10, 2025, 14:00 PM